phase readout
saveNCT06116968: An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Corxel Pharmaceuticals. Phase: PHASE3. Conditions: Obstructive Hypertrophic Cardiomyopathy
view source ↗
comments(0)
5-min edit window · permanent after that